Navigation Links
CitiusTech Completes Another Milestone Year: Revenues Grow by 59% in 2011
Date:2/15/2012

PRINCETON, New Jersey, February 15, 2012 /PRNewswire/ --

CitiusTech, a leading healthcare technology solution provider, announced that it has completed the calendar year 2011 with 59% growth in revenues. 2011 is now the fifth consecutive year that CitiusTech has recorded over 50% Y-o-Y revenue growth. In 2011, CitiusTech won the Red Herring Award for leadership in healthcare technology. CitiusTech was selected as a finalist at the 2011 American Business Awards for being one of the fastest growing technology companies in the United States.

Growth in 2011 has been driven by existing customer relationships (93% customer retention) and by new customer additions across North America and Europe.  CitiusTech also enhanced its capabilities across its key service offerings - software product engineering, professional services and healthcare BI/analytics. CitiusTech's BI-Clinical platform became the only modular BI solution to be ONC-ATCB 2011/2012 certified for all Eligible Hospital (EH) and Eligible Professional (EP) Meaningful Use Clinical Quality Measures. BI-Clinical was also one of the first BI/analytics platforms to comply with all 33 ACO quality measures that were released by CMS.

During 2011, CitiusTech's software engineering practice enabled many leading healthcare IT vendors to enhance and architect their solutions (e.g., for mobile and cloud computing) and comply with new technology and regulatory needs (including Meaningful Use, ACO etc.). In addition, CitiusTech professional services team formed strategic partnerships with HIE, EMR and clinical application organizations to help them scale their professional services organizations worldwide. With over 250 HL7 certified professionals, CitiusTech retains the distinction of having the largest number of certified interoperability professionals worldwide. CitiusTech also expanded its reach, with new offices in Princeton NJ, Singapore and India.

"2011 has been an excellent year for C
'/>"/>

SOURCE CitiusTech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Docetaxel Trial
2. Anthera Pharmaceuticals Completes $19 Million Financing; Appoints Christopher S. Henney as Chairman
3. Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing
4. Genesis Pharmaceuticals Completes Reverse Stock Split and Will Trade Under a New Symbol
5. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
6. Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director
7. China Sky One Medical, Inc. Completes Acquisition of Peng Lai Jin Chuang Company
8. Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial
9. Roche completes acquisition of ARIUS
10. Water Street Health Care Partners Completes Agreement With Gentiva Health Services to Acquire Majority Ownership of CareCentrix
11. Memory Pharmaceuticals Completes Phase 1 Multiple Ascending Dose Study of R4996/MEM 63908
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... (PRWEB) March 02, 2015 ... newly formed alliance with Shenzhen HANK Bioengineering Co., ... Ph.D. The alliance will establish a stem cells ... Province, China in September 2015. , Shenzhen HANK ... Zhang, an award-winning scientist, microbiologist and virologist, to ...
(Date:2/27/2015)... Immunovaccine Inc. (“Immunovaccine” or the “Company”) ... press release disseminated this morning by PR Web, and ... press release states that Immunovaccine has entered into a ... release did not originate from Immunovaccine and there is ... release. Please note that all official statements by ...
(Date:2/27/2015)... , Feb. 27, 2015 Research and Markets ... "Global Market Report of Trypsin" report to their ... (CAS 9002-07-7) aims at providing comprehensive data on Trypsin globally ... , North America , ... pays close attention to Trypsin This report focuses ...
(Date:2/27/2015)... -- Pfenex Inc. (NYSE MKT: PFNX), a clinical-stage biotechnology company ... that it will be presenting at CALBIO 2015 at ... at 3pm PST. Patrick Lucy, chief business officer of ... state of the biosimilar industry landscape entitled The ... more information on CALBIO 2015 and The Evolving ...
Breaking Biology Technology:Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3Immunovaccine Disclaims Hoax Press Release 2Global Market Report of Trypsin 2014-2018 2
... Ardea Biosciences, Inc. (Nasdaq: RDEA ) today ... offering of 2,750,000 shares of its common stock, offered ... share. The gross proceeds to Ardea from this offering ... underwriting discount and other estimated offering expenses payable by ...
... GAITHERSBURG, Md., Jan. 20, 2011 MedImmune,s Oncology group ... monoclonal antibody, broadly suppresses pathways that have been shown ... progression of many solid tumors. The study, published in ... (a journal of the American Association for Cancer Research), ...
... Harriet L. Robinson, Ph.D., Chief Scientific Officer at GeoVax Labs, ... company that creates, develops and tests innovative HIV/AIDS vaccines, is ... Community Awards.  Dr. Robinson will be honored at the GaBio ... Atlanta,s Fox Theater. Dr. Robinson is the developer ...
Cached Biology Technology:Ardea Biosciences Prices Public Offering of Common Stock 2Ardea Biosciences Prices Public Offering of Common Stock 3Investigational Compound Offers Novel Anti-IGF Approach To Inhibit Growth of Cancer Cells 2Investigational Compound Offers Novel Anti-IGF Approach To Inhibit Growth of Cancer Cells 3GeoVax Labs CSO Dr. Harriet L. Robinson to be Honored at 2011 Georgia Bio (GaBio) Community Awards Ceremony 2GeoVax Labs CSO Dr. Harriet L. Robinson to be Honored at 2011 Georgia Bio (GaBio) Community Awards Ceremony 3
(Date:2/10/2015)... 10, 2015  Alere Inc. (NYSE: ALR), a ... results for the quarter ended December 31, 2014. ... President of Alere said, "We made substantial progress ... the global leader in rapid diagnostics and delivering ... Health divestiture in early January enabled us to ...
(Date:2/5/2015)... , 5. Februar 2015 ... spezialisiertes Logistikunternehmen und hat eine neue Marketingkampagne ... Logistikfirma (Clinical Logistics Organization – CLO) der ... Kampagne lautet First , mit Schwerpunkt ... Foto: http://photos.prnewswire.com/prnh/20150205/173753 Logo ...
(Date:2/5/2015)... , Jan. 26, 2015   Epic Sciences , ... cancer, today announced that Murali Prahalad , Ph.D., president ... Medicine World Conference (PMWC) 2015: Silicon Valley, which is ... Mountain View, Calif. on January 26-28, 2015. ... Come of Age as Biomarkers." Last year, Epic Sciences was ...
Breaking Biology News(10 mins):Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33Alere Inc. Announces Fourth Quarter 2014 Results 34Alere Inc. Announces Fourth Quarter 2014 Results 35Alere Inc. Announces Fourth Quarter 2014 Results 36
... April 6, 2010The Life Sciences Discovery Fund (LSDF) today ... support collaborative research initiatives spearheaded by three Washington state ... diverse approaches to enhance the diagnosis and treatment of ... by Stephen Friend of Sage Bionetworks, will use powerful ...
... the most prevalent diabetes-induced complications in men; current estimates suggest ... develop some degree of ED, and in many cases diabetics ... to standard drugs. Now, in a study appearing in ... Case Western Reserve University and Albert Einstein College of Medicine ...
... PHOENIX, Ariz. April 6, 2010 Scottsdale-based TGen ... Council (GPEC) this week at BayBio2010 in an effort ... one-day conference April 7 in San Francisco sponsored by ... 1,400 bioscience companies, more than any other single region ...
Cached Biology News:Washington State Life Sciences Discovery Fund awards health research program grants 2TGen Drug Development accompanies GPEC to BayBio2010 2
... meet the needs of the ... medium supports fast cell growth ... while maintaining high cell viability ... using the Baculovirus Expression Vector ...
... part of a series of media originally developed ... et al. for the large scale propagation of ... is primarily used for the growth and maintenance ... propagation of viruses in these cell lines. One ...
... GST•Tag™ Ek Adaptor encodes a T7 promoter, ... (rbs), ATG translation initation codon and an ... has been reported to enhance the production ... its fusion partners. The GST•Tag is a ...
... Ek Adaptor encodes a T7 promoter, ... (rbs), ATG translation initation codon, and an ... a small epitope tag (11 aa) that ... protein with T7•Tag Monoclonal Antibody and purification ...
Biology Products: